Kathy Pan, MD
Medical Oncologist
Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Kathy Pan graduated the medical school from the University of California San Diego School of Medicine and completed both her residency and fellowship program at the Harbor- UCLA Medical Center. She is specialized in Medical Oncology and board certified in Internal Medicine. Dr. Pan has been in practice for more than 3 years and is affiliated with the Harbor-UCLA Medical Center. She has also contributed to three research publications.
University of California San Diego School of Medicine
Medical School
Harbor - UCLA Medical Center
Residency
Harbor - UCLA Medical Center
Fellowship
American Board of Internal Medicine
CA State Medical License 2013 - 2017
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.
Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson G; Breast Cancer Res. Treat.. 2015-12-01.
See more >>Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.
Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED; Breast Cancer Res. Treat.. 2016-04-01.
See more >>Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.
Chlebowski, R. T.,Pan, K.,Col, N. F.; Breast Cancer Res. Treat.. 2016 Oct 28.
See more >>